Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Table 3

Factors affecting mental health scores of the studied patients.

Factor		Avonex			CinnoVex
	Baseline	Stages 2–4	𝑃 value	Baseline	Stages 2–4	𝑃 value
Emotional health distress	9.4	9.3	0.757	8.8	8.9	0.685
Overall quality of life (QOL)	6.2	8.7	0.536	5.9	6.1	0.733
Emotional well-being	16.1	15.9	0.713	15.3	15.9	0.205
Role limitations due to emotional problems	13.8	13.0	0.844	12.0	11.9	0.896
Cognitive function	11.2	10.5	0.016	10.6	10.1	0.050
Mental health composite	57.4	55.1	0.197	53.6	55.2	0.845